West Nile virus (WNV) lineage 2 is associated with neurologic disease in horses and humans in South Africa. Surveillance in wildlife and nonequine domestic species during 2010-2018 identified WNV in 11 (1.8%) of 608 animals with severe neurologic and fatal infections, highlighting susceptible hosts and risk for WNV epizootics in Africa.
QIAamp viral RNA (QIAGEN, https://www.qiagen.com) (blood) or RNeasy (QIAGEN) (tissue) mini-kits under Biosafety Level 3 conditions. All specimens were subjected to 1-step nested real-time reverse transcription PCR (RT-PCR) targeting WNV (LightCycler FastStart DNA Master HybProbe; Roche Applied Science, https://www.lifescience.roche.com) (5) .
Eleven (1.8% [95% CI 0.8%-2.9%]) of the 608 animals tested positive for WNV. A total of 519 (84.5%) specimens were from animals that died, of which 78 were found dead and classified as sudden unexpected death. WNV was detected in 6 (1.7% [95% CI 0.3%-3.0%]) of 361 wildlife and 5 (1.5% [95% CI 0%-3.3%]) of 196 nonequine domestic animals but in 0 of 51 birds (Table 1) . We detected WNV RNA in 2 (2%) of 93 domestic cattle (Bos taurus), 1 (2%) of 54 African buffalo (Syncerus caffer), 1 (5%) of 22 domestic dogs (Canis lupus familiaris), 1 (33%) of 3 exotic fallow deer (Dama dama), 1 (9%) of 6 giraffes (Giraffa camelopardalis), 1 (9%) of 11 domestic goats (Capra aegagrus hircus), 1 (11%) of 9 lions (Panthera leo), 1 (2%) of 45 domestic sheep (Ovis aries), and 2 (7%) of 28 roan antelope (Hippotragus equinus) ( Table 1 ). Only 2 of 11 infected animals survived: 1 domestic bovid and the exotic fallow deer.
Virus isolation identified African horse sickness virus as a co-infection in the WNV-positive dog (ZRU358_17), confirmed by the Equine Research Centre (6) ( Table 1) . WNV neutralizing antibodies have previously been reported among dogs in South Africa, although no active infection has been described (7) . The domestic bovid (ZRU181_12_1) and buffalo (ZRU161_18) had Middleburg virus co-infections, and the giraffe had Shuni virus co-infection confirmed by differential testing (8) (9) (10) at the Centre for Viral Zoonoses (Table 1 ). In these animals, clinical signs and death could not be attributed to any of the detected viruses alone.
Positive WNV infections were detected in the Free State (2/45, 4%), Gauteng (5/192, 3%), North West (1/47, 2%), Limpopo (2/132, 2%), and Mpumalanga provinces (1/82, 1%) ( Figure 1 ). Most positive animals were reported during March-June, corresponding to the arbovirus season in South Africa (Appendix, https://wwwnc.cdc.gov/EID/ article/25/12/19-0572-App1.pdf).
We detected WNV in lung (5/11, 45%), brain (4/11, 36%), and spleen (2/11, 18%) tissue and in blood (2/11,
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18%) ( Table 1) . Clinical signs noted in WNV-positive animals included neurologic (4/8, 50%) and respiratory (3/8, 38%); 2 animals with neurologic signs also had pyrexia ( Table 2 ). The lion (ZRU297_17) and giraffe (ZRU87_18) were found dead (2/11, 18%); thus, no clinical signs were reported. The WNV-positive sheep (ZRU159_18), an indigenous Dorper, was a stillborn fetus with cerebral edema. In sheep, WNV is reported to cause neurologic symptoms (11) but has not been associated with stillbirths. The roan antelope (ZRU61_16_2), the domestic bovid (ZRU181_12_1), and the sheep fetus represented WNV-positive specimens among a cluster of animals with similar signs potentially representing larger outbreaks in these areas. Despite extensive screening for arboviruses, the causative link between the clinical presentation of the various species and the evidence of WNV infection must be regarded with caution because we could not exclude all other possible infectious and noninfectious etiologies.
We subjected positive specimens to Sanger sequencing (Inqaba biotech, https://www.inqababiotec.co.za) and Figure 2 ). One previous report found a lineage 1 strain that clustered with lineage 1 strains previously identified in South Africa (12) . We used an epitope-blocking ELISA (13) to screen serum for WNV antibodies in 50 white rhinoceros (Ceratotherium simum) collected by the South African National Parks in March 2014 and 45 African buffalo in June 2016, all from KNP, and from 34 Nile crocodiles (Crocodylus niloticus) collected from northern KwaZulu-Natal during 2009-2012. We coated flat-bottom 96-well microtiter plates (CELLSTAR, Sigma Aldricht, https://www.sigmaaldrich.com) with 1:800 dilution of WNV cell lysate antigen, prepared according to (14) using strain HS101/08, passage 6, South Africa and WNV hyperimmune mouse ascites fluid polyclonal antibody (FC-M30200-06-1, Centers for Disease Control and Prevention, https://www. cdc.gov/ncezid/dvbd/specimensub/arc) diluted 1:400 and horseradish peroxidase-conjugated rabbit antimouse IgG (BioRad Laboratories, https://www.bio-rad.com) (1:2000 dilution). We calculated the percentage inhibition of antibody binding with a cutoff value of 40% and confirmed positive reactions by microtiter virus neutralization test using a 10 3 50% tissue culture infectious dose stock culture (MRM61C, passage 6) (15) . We detected WNV-specific antibodies in serum of 25 (50%) of white rhinoceros, of which 20 (80%) demonstrated neutralization at all 3 dilutions (1:8, 1:16, and 1:32) and 5 showed no neutralization, suggesting high-level WNV exposure. This finding highlights the prevalence of WNV in KNP despite a low number of reported clinical infections. No buffaloes or crocodiles were seropositive.
Conclusions
We recorded WNV (lineages 1 and 2) in wildlife and nonequine domestic animals in South Africa. Seroconversion to WNV was demonstrated in asymptomatic white rhinoceros from KNP. The data suggest severe disease and neurologic signs occur in species other than horses; these signs may be used for surveillance in areas of Africa where horses are less common to predict WNV outbreaks and predict spillover events into the human population. Wildlife and nonequine domestic animals are not as closely monitored for WNV as horses, and early detection is less likely. The short viremia associated with WNV infection may result in underreporting of positive animals if only RT-PCR is used for diagnosis, but a lack of conjugates for wildlife species complicates development of IgM ELISA. The epitopeblocking ELISA and microtiter virus neutralization test can be used for seroprevalence studies in animals other than horses because they are species-independent but do not differentiate between IgM and IgG and are not quantitative. Future work should focus on assay development for species other than horses. (3, 12) . Reference strains, GenBank accession numbers, and origins are as indicated in (4) . GenBank accession numbers for the newly sequenced strains are ZRU87_18, MN270988; ZRU159_18_SA, MN270989; ZRU161_18_SA, MN27099; and ZRU181_12_1, KY176733. The sequences for strains ZRU358/17, ZRU061/16/2, and ZRU297/17 were <200 bp long and therefore could not be submitted to GenBank; the sequence data are available from the authors. Scale bar indicates nucleotide substitutions per site.
